The Board of Directors approves the results for the first semester 2020

Board of Directors of Emak S.p.A.

Approved consolidated results for the first semester 2020

Significant recovery in turnover in the second quarter (+7.3%)

Revenues from sales: € 247.5 million compared to € 243 million in the first semester 2019

EBITDA adjusted (*): € 33.2 million compared to € 31.1 million in the first semester 2019

EBIT: € 21.8 million compared to € 17.9 million in the first semester 2019

Consolidated net income: € 10.9 million compared to € 10.5 million in the first semester 2019

Net negative financial position: € 149.6 million (€ 120.7 million net of IFRS 16 effect), compared to € 169.1 million at 30 June 2019 (€ 136.3 million net of IFRS 16 effect).

The Board of Directors approves the results for the first semester 2020

Articoli correlati

The Board of Directors approves the consolidated results for the first half 2016

Failure to submit minority shareholders'list of candidates for Board of Statutory Auditors

Finalized the closing of the acquisition of 30% of Cifarelli S.p.A.

Publication of documentation related to the Ordinary Shareholders’ Meeting and of Consolidated Non-Financial Information